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Abstract 
The discovery of dendritic cells (DCs) was followed by an intensive research period aiming at 
the identification of mechanisms that could induce or inhibit adaptive immune responses 
through the manipulation of these cells. Only in the recent years the role of metabolic 
pathways in DC regulation has started to become clear. Metabolic regulators might allow the 
generation of DCs with prominent immunogenicity or the interference with chronic immune 
activation accompanying autoimmune responses or HIV-1 infection. Therefore the focus of 
this thesis is on novel mechanisms that regulate DC function, the relevance of these in 
generation of DC vaccines and on the delineation of pathways that potentially contribute to 
the unbalanced immune responses during HIV-1 infection. In paper I, we show that lactate 
inhibits the differentiation of human inflammatory DCs in a cell culture concentration 
dependent manner. DCs differentiating in the presence of low lactate concentrations are 
immune-stimulatory as shown by the production of inflammatory cytokines, the induction of 
Th1 differentiation and the migration in a trans-well system. In contrast, DCs from dense 
cultures produce high levels of IL-10 and trans-differentiate into osteoclasts. In paper II, we 
demonstrate an efficient modulation of DC vaccine immunogenicity by modulating cell 
culture density during DC development. DCs from sparse cultures migrated more efficiently 
to draining lymph nodes and induced more robust antigen-specific T cell activation in vivo as 
compared to dense DC cultures. In addition, DCs developing in sparse cultures exhibited a 
transcriptional profile associated with increased cholesterol and lipid biosynthesis, suggesting 
a link between lipid biosynthetic pathways and DC activities. In, paper III we explored the 
role of DC plasticity in regulating DC/HIV-1 interactions. We showed that DC responses to 
HIV-1 were largely dependent on the functional characteristics of the cells and strain-specific 
features of the virus. Suppressed DCs up-regulated production of inflammatory cytokines 
after HIV-1 exposure, whereas the virus could block cytokine production in the more 
immunogenic DC types suggesting unique viral pathways induced in the different DC 
lineages. Finally, in Paper IV we provided evidence that the population of CD4+CD70+ T 
cells is expanded in lymphopenic HIV-1 infected individuals potentially contributing to B cell 
abnormalities. In conclusion, the studies presented in this thesis identified new mechanisms 
and metabolic components that regulate DC immunogenicity and novel immune-modulatory 
pathways operating during HIV-1 infection. 
 
 
